Dr. Crystal Proud

(757) 668-9920
Board Certifications

American Board of Psychiatry & Neurology


Medical School: Eastern Virginia Medical School

Residency: Emory University

Fellowship: Stanford University

Fellowship: Stanford University


In addition to caring for children with general neurologic conditions, Dr. Proud is a board-certified pediatric neuromuscular neurologist, meaning she has expertise in caring for children with spinal muscular atrophy, Charcot Marie Tooth neuropathy, muscular dystrophies, congenital myopathies, and myasthenia gravis.

Dr. Proud received subspecialty training at Stanford University in both child neurology and pediatric neuromuscular neurology, participating in clinical research trials for children with muscular dystrophy and SMA. She has continued this interest at CHKD, where CHKD has research opportunities for children with various neuromuscular conditions.

CHKD offers a multi-disciplinary Muscular Dystrophy Association clinic where Dr. Proud works collaboratively with many subspecialists to provide the best care for children with nerve and muscle disease. She has seen a remarkable optimism and new hope for effective treatments in children affected by these diagnoses and works with great compassion and enthusiasm with families in clinic.

Honors & Awards
Clinical Interests
Research Areas
  • Neuromuscular disease
  • Muscular dystrophy
  • Spinal muscular atrophy
  • Dr. Proud's published research can be viewed at PubMed.
A Note From Dr. Proud

"While I trained at excellent centers around the country, I returned home to where my heart is. CHKD is a pillar in this community, and it is a privilege to work here."


Dr. Proud Spearheads Efforts to have Newborns Screened for SMA

Kaeli Price, a 3-month-old patient at CHKD, was the first patient in Virginia to receive a new gene therapy drug and life-saving treatment since it was approved by the FDA in May. Watch Kaeli's story here and see how Dr. Crystal Proud, a neurologist at CHKD, is spearheading efforts to have newborns screened for SMA, so early interventions like this can provide the best possible outcomes for these children.

Dr. Proud on NeurologyLive

Learn about therapeutic advances that are leading to new treatment options for SMA.